Do Analysts Think CRISPR Therapeutics AG (CRSP) Is Still Worth Buying In 2024?

CRISPR Therapeutics AG (NASDAQ:CRSP) does about 1.18M shares in volume on a normal day but saw 1037339 shares change hands in the recent trading day. The company now has a market cap of 3.85B USD. Its current market price is $45.20, marking a decrease of -0.64% compared to the previous close of $45.49. The 52 […]